Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLK12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANKRD46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
E2F7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMT11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF503 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728554 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GAS7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERLEC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK1IP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TARSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
POMK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on